Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

NeuroScientific specialist hire sets stage for major Crohn’s trial

Southern Star Research will manage sites and logistics for the study after all five patients in an earlier trial improved, the company said.

Summary by Sydney Morning Herald
NeuroScientific Biopharmaceuticals has hired Southern Star Research for a phase two trial of its StemSmart Crohn’s disease therapy in Australia and the US.

4 Articles

Sydney Morning HeraldSydney Morning Herald
+3 Reposted by 3 other sources
Lean Left

NeuroScientific specialist hire sets stage for major Crohn’s trial

NeuroScientific Biopharmaceuticals has hired Southern Star Research for a phase two trial of its StemSmart Crohn’s disease therapy in Australia and the US.

·North Sydney, Australia
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources lean Left
75% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Sydney Morning Herald broke the news in North Sydney, Australia on Thursday, October 1, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Queensland, Australia icon

Queensland, Australia

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal